Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iSIL in HCV-HIV Co-infected Individuals With Advanced Liver Fibrosis
NCT01816490Phase 2Completed
- Sponsor
- University of Zurich
- Start
- Apr 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of silibinin in hepatitis C (HCV), sponsored by University of Zurich. Started Apr 2013; status: completed.
02
Drugs
silibinin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01816490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01816490.